PSIP1 and systemic lupus erythematosus: In SLE patients, the prevalence of anti-DFS70 antibodies was 20.7% (176/851), which was significantly higher than HC (9.5% (20/211), p = 0.0002) and DC (10.8% (21/194), p = 0.002).